Selected research
Industry Research
Pharmaceutical Grade Melatonin Industry Research Report 2026
Market perspective
The global Pharmaceutical Grade Melatonin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharmaceutical Grade Melatonin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharmaceutical Grade Melatonin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Grade Melatonin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharmaceutical Grade Melatonin include Teva, Mylan, Pharma Nord, Neurim Pharmaceuticals, Flynn Pharma, Aspen Pharmacare, Alturix and AGB-Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmaceutical Grade Melatonin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Grade Melatonin Market by Company
Teva
Mylan
Pharma Nord
Neurim Pharmaceuticals
Flynn Pharma
Aspen Pharmacare
Alturix
AGB-Pharma
Pharmaceutical Grade Melatonin Segment by Type
Tablets
Oral Solution
Pharmaceutical Grade Melatonin Segment by Application
Hospital and Clinic
Pharmacy
Other
Pharmaceutical Grade Melatonin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Melatonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Melatonin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Melatonin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceutical Grade Melatonin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceutical Grade Melatonin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceutical Grade Melatonin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Oral Solution
Applications
- Hospital and Clinic
- Pharmacy
- Other
Companies covered
- Teva
- Mylan
- Pharma Nord
- Neurim Pharmaceuticals
- Flynn Pharma
- Aspen Pharmacare
- Alturix
- AGB-Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pharmaceutical Grade Melatonin Market Size (2021-2032)
- 2.2.2 Global Pharmaceutical Grade Melatonin Sales (2021-2032)
- 2.2.3 Global Pharmaceutical Grade Melatonin Market Average Price (2021-2032)
- 2.3 Pharmaceutical Grade Melatonin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Oral Solution
- 2.4 Pharmaceutical Grade Melatonin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital and Clinic
- 2.4.3 Pharmacy
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharmaceutical Grade Melatonin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pharmaceutical Grade Melatonin Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Grade Melatonin Revenue of Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Grade Melatonin Average Price by Manufacturers (2021-2026)
- 3.5 Global Pharmaceutical Grade Melatonin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pharmaceutical Grade Melatonin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pharmaceutical Grade Melatonin, Product Type & Application
- 3.8 Global Manufacturers of Pharmaceutical Grade Melatonin, Established Date
- 3.9 Global Pharmaceutical Grade Melatonin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Pharmaceutical Grade Melatonin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Grade Melatonin Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Pharmaceutical Grade Melatonin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Pharmaceutical Grade Melatonin Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 Pharma Nord
- 4.3.1 Pharma Nord Company Information
- 4.3.2 Pharma Nord Business Overview
- 4.3.3 Pharma Nord Pharmaceutical Grade Melatonin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pharma Nord Pharmaceutical Grade Melatonin Product Portfolio
- 4.3.5 Pharma Nord Recent Developments
- 4.4 Neurim Pharmaceuticals
- 4.4.1 Neurim Pharmaceuticals Company Information
- 4.4.2 Neurim Pharmaceuticals Business Overview
- 4.4.3 Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Product Portfolio
- 4.4.5 Neurim Pharmaceuticals Recent Developments
- 4.5 Flynn Pharma
- 4.5.1 Flynn Pharma Company Information
- 4.5.2 Flynn Pharma Business Overview
- 4.5.3 Flynn Pharma Pharmaceutical Grade Melatonin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Flynn Pharma Pharmaceutical Grade Melatonin Product Portfolio
- 4.5.5 Flynn Pharma Recent Developments
- 4.6 Aspen Pharmacare
- 4.6.1 Aspen Pharmacare Company Information
- 4.6.2 Aspen Pharmacare Business Overview
- 4.6.3 Aspen Pharmacare Pharmaceutical Grade Melatonin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Aspen Pharmacare Pharmaceutical Grade Melatonin Product Portfolio
- 4.6.5 Aspen Pharmacare Recent Developments
- 4.7 Alturix
- 4.7.1 Alturix Company Information
- 4.7.2 Alturix Business Overview
- 4.7.3 Alturix Pharmaceutical Grade Melatonin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Alturix Pharmaceutical Grade Melatonin Product Portfolio
- 4.7.5 Alturix Recent Developments
- 4.8 AGB-Pharma
- 4.8.1 AGB-Pharma Company Information
- 4.8.2 AGB-Pharma Business Overview
- 4.8.3 AGB-Pharma Pharmaceutical Grade Melatonin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AGB-Pharma Pharmaceutical Grade Melatonin Product Portfolio
- 4.8.5 AGB-Pharma Recent Developments
5 Global Pharmaceutical Grade Melatonin Market Scenario by Region
- 5.1 Global Pharmaceutical Grade Melatonin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharmaceutical Grade Melatonin Sales by Region: 2021-2032
- 5.2.1 Global Pharmaceutical Grade Melatonin Sales by Region: 2021-2026
- 5.2.2 Global Pharmaceutical Grade Melatonin Sales by Region: 2027-2032
- 5.3 Global Pharmaceutical Grade Melatonin Revenue by Region: 2021-2032
- 5.3.1 Global Pharmaceutical Grade Melatonin Revenue by Region: 2021-2026
- 5.3.2 Global Pharmaceutical Grade Melatonin Revenue by Region: 2027-2032
- 5.4 North America Pharmaceutical Grade Melatonin Market Facts & Figures by Country
- 5.4.1 North America Pharmaceutical Grade Melatonin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pharmaceutical Grade Melatonin Sales by Country (2021-2032)
- 5.4.3 North America Pharmaceutical Grade Melatonin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pharmaceutical Grade Melatonin Market Facts & Figures by Country
- 5.5.1 Europe Pharmaceutical Grade Melatonin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pharmaceutical Grade Melatonin Sales by Country (2021-2032)
- 5.5.3 Europe Pharmaceutical Grade Melatonin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pharmaceutical Grade Melatonin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pharmaceutical Grade Melatonin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pharmaceutical Grade Melatonin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pharmaceutical Grade Melatonin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pharmaceutical Grade Melatonin Market Facts & Figures by Country
- 5.7.1 South America Pharmaceutical Grade Melatonin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pharmaceutical Grade Melatonin Sales by Country (2021-2032)
- 5.7.3 South America Pharmaceutical Grade Melatonin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Pharmaceutical Grade Melatonin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pharmaceutical Grade Melatonin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pharmaceutical Grade Melatonin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pharmaceutical Grade Melatonin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pharmaceutical Grade Melatonin Sales by Type (2021-2032)
- 6.1.1 Global Pharmaceutical Grade Melatonin Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pharmaceutical Grade Melatonin Sales Market Share by Type (2021-2032)
- 6.2 Global Pharmaceutical Grade Melatonin Revenue by Type (2021-2032)
- 6.2.1 Global Pharmaceutical Grade Melatonin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pharmaceutical Grade Melatonin Revenue Market Share by Type (2021-2032)
- 6.3 Global Pharmaceutical Grade Melatonin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pharmaceutical Grade Melatonin Sales by Application (2021-2032)
- 7.1.1 Global Pharmaceutical Grade Melatonin Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pharmaceutical Grade Melatonin Sales Market Share by Application (2021-2032)
- 7.2 Global Pharmaceutical Grade Melatonin Revenue by Application (2021-2032)
- 7.2.1 Global Pharmaceutical Grade Melatonin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pharmaceutical Grade Melatonin Revenue Market Share by Application (2021-2032)
- 7.3 Global Pharmaceutical Grade Melatonin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pharmaceutical Grade Melatonin Value Chain Analysis
- 8.1.1 Pharmaceutical Grade Melatonin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pharmaceutical Grade Melatonin Production Mode & Process
- 8.2 Pharmaceutical Grade Melatonin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pharmaceutical Grade Melatonin Distributors
- 8.2.3 Pharmaceutical Grade Melatonin Customers
9 Global Pharmaceutical Grade Melatonin Analyzing Market Dynamics
- 9.1 Pharmaceutical Grade Melatonin Industry Trends
- 9.2 Pharmaceutical Grade Melatonin Industry Drivers
- 9.3 Pharmaceutical Grade Melatonin Industry Opportunities and Challenges
- 9.4 Pharmaceutical Grade Melatonin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst